Animal Therapeutics and Diagnostics: Industry Report

Animal Therapeutics and Diagnostics

Product Type:

Published by:

Published:

Product Code:

Description

Table of Contents

INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

INTENDED AUDIENCE

SCOPE OF REPORT

INFORMATION SOURCES

RELATED BCC RESEARCH REPORT

ANALYST CREDENTIALS

BCC RESEARCH ONLINE SERVICES

DISCLAIMER

SUMMARY

SUMMARY TABLE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, THROUGH 2013 ($ MILLIONS)

SUMMARY FIGURE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, 2006-2013 ($ MILLIONS)

LEADING PRODUCTS AND MANUFACTURERS

INDUSTRY OVERVIEW

ANIMAL ANATOMY AND PHYSIOLOGY

ANIMAL ANATOMY AND PHYSIOLOGY (CONTINUED)

REPRODUCTIVE SYSTEM

TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES

AVIAN ANATOMY

Avian Anatomy (Continued)

ANIMAL POPULATIONS

COMPANION ANIMALS

TABLE 2 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2007, UNITED STATES (THOUSANDS)

FARM ANIMALS

TABLE 3 REPORTED 2005 AND ESTIMATED 2006* POPULATION OF FARM ANIMALS, UNITED STATES (MILLIONS)

TABLE 4 LIFESPAN OF COMMON PET AVIAN SPECIES

TABLE 4 (CONTINUED)

COMPANION ANIMAL DISEASES

INFECTIOUS DISEASES

Viruses

Adenovirus

Avian Influenza

Coronavirus

Distemper

Eastern Equine Encephalitis

Equine Viral Arteritis

Feline Calicivirus and Feline Herpes Virus

Feline Immunosuppressive Virus

Feline Infectious Peritonitis Virus

Feline Leukemia Virus

Infectious Hepatitis

Internal Papillomatosis of Parrots

Newcastle Disease

Pacheco’s Disease

Parainfluenza Virus

Paramyxoviruses

Parvovirus

Polyomavirus

Poxviruses

Psittacine Beak and Feather Disease

Rabies

Reovirus

West Nile Virus

Bacteria

Black Tongue

Bordetella

Brucellosis

Campylobacteriosis

Chlamydia

Leptospirosis

Lyme Disease

Q-Fever

Respiratory Mycoplasmosis

Spirochaetaceae

Tetanus

ALLERGY AND INFLAMMATORY DISEASES

Allergies

Arthritis

Asthma

Dermatitis

Eosinophilic Granuloma Complex

Gout

Inflammatory Bowel Disease

METABOLIC DISEASES

Cushing’s Syndrome

Diabetes Mellitus

Thyroid Disease

Pancreatitis

Metabolic Bone Disease in Birds

PARASITIC DISEASES

Ear Mites

Fleas

Heartworm

Hemobartonellosis

Feline Scabies

Lice

Sarcoptic Mange

Worms

Urinary Diseases

Glomerulonephritis

Feline Lower Urinary Tract Disease

Other Diseases

Equine Protozoal Myelitis

Leptospirosis and Equine Recurrent Uveitis

Neoplastic Disease

Neoplastic Disease (Continued)

Heart Disease

FOOD ANIMAL DISEASES

INFECTIOUS DISEASES

Viruses and Prions

Avian Pneumovirus

Bovine Spongiform Encephalopathy

Bovine Viral Diarrhea

Bovine Viral Diarrhea (Continued)

Classical Swine Fever

Foot and Mouth Disease

Furunculosis

Infectious Pancreatic Necrosis

Marek’s Disease

Pathogenic Avian Influenza

Q-Fever

Vesicular Stomatitis

Bacteria

Anthrax

Blackleg

Conjunctivitis

Tetanus

OTHER DISEASES OF FOOD ANIMALS

Heartwater

Pneumonia

Texas Cattle Fever

ZOONOTIC DISEASES

ZOONOTIC DISEASES (CONTINUED)

TABLE 5 COMMON EXAMPLES OF ZOONOTIC DISEASES

ISSUES AFFECTING THE MARKET

ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS

Therapeutic Use

TABLE 6 APPROVED ANTIBIOTICS AND SULFONAMIDES USED IN DIARY AND BEEF CATTLE PRODUCTION IN U.S.

TABLE 7 APPROVED ANTIBIOTICS USED IN HOG PRODUCTION IN U.S.

TABLE 8 APPROVED ANTIBIOTICS USED IN SHEEP PRODUCTION IN U.S

TABLE 9 APPROVED ANTIBIOTICS USED IN CHICKEN AND TURKEY PRODUCTION IN U.S.

Resistance

Human Side-Effects

Microbial Ecology

PROBIOTICS

LEGAL AND REGULATORY ISSUES

Minimally and Highly Regulated Products

Animal Drug User Fee Act of 2003

ANIMAL HEALTH INSURANCE

Animal Health Insurance (Continued)

SPRAY-ON DRUGS

BIOTECHNOLOGY

ANIMAL OBESITY

Causes

Weight Reduction

NEW TRENDS IN AGING DISEASES

COMPANION PET OWNERSHIP

DEMAND IN THE VETERINARY SERVICE INDUSTRY

TABLE 10 ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN THE UNITED STATES BY TYPE OF PRACTICE, 2007

LIFE CYCLE APPROACH

INTERNATIONAL ISSUES AND TRENDS

TABLE 11 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2005, JAPAN AND AUSTRALIA (MILLIONS)

TABLE 12 ESTIMATED POPULATIONS OF FARM ANIMALS FOR 2004, BRAZIL (MILLIONS)

ANIMAL VACCINES

OVERVIEW

PRODUCT DESCRIPTION

ACTIVE IMMUNITY

PASSIVE IMMUNITY

OTHER TYPES

TARGET SPECIES AND PROVIDERS

TABLE 13 VACCINES BY TARGET SPECIES AND PROVIDERS

TABLE 13 (CONTINUED)

COMPANION ANIMAL VACCINES

BOEHRINGER INGELHEIM

FORT DODGE

HESKA

MERIAL

NOVARTIS

SCHERING-PLOUGH

FOOD ANIMAL VACCINES

ALPHARMA

BAYER

BOEHRINGER INGELHEIM

FORT DODGE

INTERVET

MERIAL

NOVARTIS

PFIZER

SCHERING-PLOUGH

Poultry

Poultry (Continued)

Cattle and Sheep

Swine

Rabies

Fish

MARKET ANALYSIS AND CONCLUSIONS

MARKETS BY USE OR APPLICATION

TABLE 14 GLOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 1 GOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, 2006-2013 ($ MILLIONS)

VACCINE MARKET BY TYPE

TABLE 15 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, THROUGH 2013 ($ MILLIONS)

FIGURE 2 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, 2006-2013 ($ MILLIONS)

MARKETS BY GEOGRAPHICAL REGION

TABLE 16 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%/$ MILLIONS)

FIGURE 3 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%)

COMPETITIVE SUMMARY

Intervet

Schering-Plough

Fort Dodge

Other Companies

TABLE 17 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%/$ MILLIONS)

FIGURE 4 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%)

ANIMAL PHARMACEUTICAL PRODUCTS

OVERVIEW

PRODUCT DESCRIPTION

ALLERGY AND RESPIRATORY DRUGS

TARGET SPECIES AND PROVIDERS

TABLE 18 ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES AND PROVIDERS

ANTI-INFECTIVES AND ANTIFUNGALS

Bayer

Boehringer Ingelheim

Elanco

Esteve

Fort Dodge

ECO

Novartis

Pfizer

Schering-Plough

Target Species and Providers

TABLE 19 ANTI-INFECTIVES BY TARGET SPECIES AND PROVIDERS

TABLE 19 (CONTINUED)

ANTI-INFLAMMATORIES AND ANALGESICS

Bayer

Boehringer Ingelheim

Elanco

Esteve

Fort Dodge

Bioniche

Novartis

Pfizer

Schering-Plough

Luitpold Animal Health

Target Species and Providers

TABLE 20 ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES AND PROVIDERS

METABOLIC DRUGS

Target Species and Providers

TABLE 21 METABOLIC DRUGS BY TARGET SPECIES AND PROVIDERS

PARASITICIDES

Bayer

Boehringer-Ingelheim

Esteve

Fort Dodge

IDEXX

ECO

Merial

Novartis

Pfizer

Schering-Plough

Virbac

Target Species and Providers

TABLE 22 PARASITICIDES BY TARGET SPECIES AND PROVIDERS

TABLE 22 (CONTINUED)

OTHER PHARMACEUTICALS

Esteve

Merial

Schering-Plough

Dental

Virbac

Biopure

Novartis

Target Species and Providers

TABLE 23 OTHER PHARMACEUTICALS BY TARGET SPECIES AND PROVIDERS

MARKET ANALYSIS AND CONCLUSIONS

MARKETS BY USE OR APPLICATION

Allergy and Respiratory Market

TABLE 24 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 5 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, 2006-2013 ($ MILLIONS)

Anti-Infective Market

TABLE 25 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 6 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, 2006-2013 ($ MILLIONS)

Anti-Inflammatory Market

TABLE 26 GLOBAL MARKET ANALYSIS FOR ANTIINFLAMMATORIES AND ANALGESICS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 7 GLOBAL MARKET ANALYSIS FOR ANTIINFLAMMATORIES AND ANALGESICS BY USE, 2006-2013 ($ MILLIONS)

Metabolic Drug Market

TABLE 27 GLOBAL MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 8 GLOBAL MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, 2006-2013 ($ MILLIONS)

Parasiticide Market

TABLE 28 GLOBAL MARKET ANALYSIS FOR PARASITICIDES BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 9 GLOBAL MARKET ANALYSIS FOR PARASITICIDES BY USE, 2006-2013 ($ MILLIONS)

Other Pharmaceuticals

TABLE 29 GLOBAL MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 10 GLOBAL MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, 2006-2013 ($ MILLIONS)

TOTAL PHARMACEUTICALS

TABLE 30 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 11 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE, 2006-2013 ($ MILLIONS)

Summary—Pharmaceutical Markets

TABLE 31 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2013 ($ MILLIONS)

FIGURE 12 GLOBAL MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2006-2013 ($ MILLIONS)

MARKETS BY GEOGRAPHICAL REGION

TABLE 32 DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2007 (%)

FIGURE 13 DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD REGION, 2007 (%)

COMPETITIVE SUMMARY

TABLE 33 COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)

FIGURE 14 COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES, 2007 (%)

ANIMAL FEED ADDITIVES

OVERVIEW

PRODUCT DESCRIPTION

AMINO ACIDS

TARGET SPECIES AND PROVIDERS

TABLE 34 AMINO ACIDS BY TARGET SPECIES AND PROVIDERS

MEDICINAL ADDITIVES

Alpharma

Elanco

ECO

Novartis

Merial

Pfizer

Schering-Plough

Boehringer Ingelheim

Target Species and Providers

TABLE 35 MEDICINAL ADDITIVES BY TARGET SPECIES AND PROVIDERS

NUTRITIONAL SUPPLEMENTS

NUTRITIONAL SUPPLEMENTS (CONTINUED)

TARGET SPECIES AND PROVIDERS

TABLE 36 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES AND PROVIDERS

VITAMINS AND MINERALS

BEAPHAR

ESTEVE

ADISSEO

MOSAIC (FORMERLY IMC GLOBAL)

DSM NUTRITIONAL

SCHERING-PLOUGH

CHURCH & DWIGHT CO

VIRBAC

TARGET SPECIES AND PROVIDERS

TABLE 37 VITAMINS AND MINERALS BY TARGET SPECIES AND PROVIDERS

TABLE 37 (CONTINUED)

MARKET ANALYSIS AND CONCLUSION

MARKETS BY USE OR APPLICATION

Amino Acid Market

TABLE 38 GLOBAL MARKET ANALYSIS FOR AMINO ACIDS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 15 MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2006-2013 ($ MILLIONS)

Medicinal Feed Additive Market

TABLE 39 GLOBAL MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 16 GLOBAL MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, 2006-2013 ($ MILLIONS)

Nutritional Supplement Market

TABLE 40 GLOBAL MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 17 GLOBAL MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, 2006-2013 ($ MILLIONS)

Vitamin and Mineral Market

TABLE 41 GLOBAL MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 18 GLOBAL MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, 2006-2013 ($ MILLIONS)

Total Feed Additive Market

TABLE 42 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 19 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, 2006-2013 ($ MILLIONS)

FEED ADDITIVE MARKET BY TYPE

TABLE 43 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2013 ($ MILLIONS)

FIGURE 20 GLOBAL MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2006-2013 ($ MILLIONS)

MARKETS BY GEOGRAPHICAL REGION

TABLE 44 DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2007 (%/$ MILLIONS)

FIGURE 21 DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD REGION, 2007 (%)

COMPETITIVE SUMMARY

TABLE 45 COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)

FIGURE 22 COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR REVENUES, 2007 (%)

ANIMAL DIAGNOSTICS

OVERVIEW

PRODUCT DESCRIPTION

HESKA

IDEXX

SNAP

PETCHEK

DIASYSTEMS

HERDCHEK

FLOCKCHEK

Guildhay and Svanovir

SCHERING-PLOUGH

SYNBIOTICS

TARGET SPECIES AND PROVIDERS

TABLE 46 DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS

TABLE 46 (CONTINUED)

MARKET ANALYSIS AND CONCLUSION

MARKETS BY USE OR APPLICATION

TABLE 47 GLOBAL MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)

FIGURE 23 GLOBAL MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS BY USE, 2006-2013 ($ MILLIONS)

DIAGNOSTIC MARKET BY TYPE

TABLE 48 ESTIMATED REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2013 ($ MILLIONS)

FIGURE 24 ESTIMATED REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2006-2013 ($ MILLIONS)

MARKETS BY GEOGRAPHICAL REGION

TABLE 49 DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2007 (%/$ MILLIONS)

FIGURE 25 DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD REGION, 2007 (%)

COMPETITIVE SUMMARY

TABLE 50 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%/$ MILLIONS)

FIGURE 26 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%)

MARKET SUMMARY

TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET ANALYSIS

TABLE 51 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2013 ($ MILLIONS)

FIGURE 27 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY TYPE, THROUGH 2013 ($ MILLIONS)

TABLE 52 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, THROUGH 2013 ($ MILLIONS)

FIGURE 28 GLOBAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, 2006-2013 ($ MILLIONS)

INDUSTRY PARTICIPANTS BY TYPE

TABLE 53 MAJOR INDUSTRY PARTICIPANTS BY ANIMAL PRODUCT TYPE

TOTAL COMPETITIVE ANALYSIS

TABLE 54 TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2007 (%/$ MILLIONS)

FIGURE 29 TOTAL COMPETITIVE SUMMARY FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY COMPETITOR REVENUES, 2007 (%)

COMPANY PROFILES

ADISSEO FRANCE S.A.S

ALPHARMA, INC.

BASF ANIMAL NUTRITION (BASF AG)

BAYER ANIMAL HEALTH

BOEHRINGER INGELHEIM CORP

DSM NUTRITIONAL PRODUCTS

ELANCO ANIMAL HEALTH

EVONIK INDUSTRIES

FORT DODGE ANIMAL HEALTH

HESKA CORP

IDEXX LABORATORIES, INC.

INTERVET INTERNATIONAL BV

IVX ANIMAL HEALTH, INC

MERIAL ANIMAL HEALTH, LTD

MOSAIC

NOVARTIS ANIMAL HEALTH, INC

NOVARTIS AG

NOVUS INTERNATIONAL, INC.

PFIZER ANIMAL HEALTH

SCHERING-PLOUGH ANIMAL HEALTH

SCHERING-PLOUGH CORP

VIRBAC SA

VIRBAC SA (CONTINUED)

APPENDIX I: LEADING MANUFACTURES AND AFFILIATED COMPANIES

ACRUX, LTD

ADISSEO FRANCE S.A.S.

AJINOMOTO CO., LTD.

AKZO NOBEL N.V.

ALPHARMA, INC.

BASF AG

BASF ANIMAL NUTRITION

BAYER AG

BAYER HEALTHCARE, LLC

BEAPHAR B.V.

BEN VENUE LABORATORIES, INC.

BOEHRINGER INGELHEIM CHEMICALS, INC.

BOEHRINGER INGELHEIM CORP

BOEHRINGER INGELHEIM GMBH

BOEHRINGER INGELHEIM VETMEDICA, INC.

DSM

DSM NUTRITIONAL PRODUCTS

ECO ANIMAL HEALTH

ELANCO ANIMAL HEALTH

ELI LILLY & CO

ESTEVE

EVONIK DEGUSSA GMBH

FORT DODGE ANIMAL HEALTH

HESKA CORP

IDEXX LABORATORIES, INC.

INTERVET INTERNATIONAL BV

LUITPOLD ANIMAL HEALTH

MOSAIC

MERIAL ANIMAL HEALTH, LTD

NOVARTIS AG

NOVARTIS ANIMAL HEALTH, INC

NOVARTIS ANIMAL VACCINES, INC.

NOVUS INTERNATIONAL, INC.

PFIZER ANIMAL HEALTH

PFIZER, INC

ROXANE LABORATORIES, INC.

SCHERING-PLOUGH ANIMAL HEALTH

SCHERING-PLOUGH CORP

SYNBIOTICS CORP

VIRBAC S.A.

WYETH

APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS

AMERICAN ASSOCIATION OF FELINE PRACTITIONERS

AMERICAN VETERINARY MEDICAL ASSOCIATION

CANADIAN VETERINARY MEDICAL ASSOCIATION

UNITED STATES DEPARTMENT OF AGRICULTURE

UNITED STATES FOOD AND DRUG ADMINISTRATION

LIST OF TABLES

SUMMARY TABLE TOTAL ANIMAL THERAPEUTIC AND DIAGNOSTIC MARKET BY MAJOR SEGMENT, THROUGH 2013 ($ MILLIONS)

TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES

TABLE 2 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2007, UNITED STATES (THOUSANDS)

TABLE 3 REPORTED 2005 AND ESTIMATED 2006* POPULATION OF FARM ANIMALS, UNITED STATES (MILLIONS)

TABLE 4 LIFESPAN OF COMMON PET AVIAN SPECIES

TABLE 5 COMMON EXAMPLES OF ZOONOTIC DISEASES

TABLE 6 APPROVED ANTIBIOTICS AND SULFONAMIDES USED IN DIARY AND BEEF CATTLE PRODUCTION IN U.S

TABLE 7 APPROVED ANTIBIOTICS USED IN HOG PRODUCTION IN U.S

TABLE 8 APPROVED ANTIBIOTICS USED IN SHEEP PRODUCTION IN U.S

TABLE 9 APPROVED ANTIBIOTICS USED IN CHICKEN AND TURKEY PRODUCTION IN U.S

TABLE 10 ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN THE UNITED STATES BY TYPE OF PRACTICE, 2007

TABLE 11 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOR 2005, JAPAN AND AUSTRALIA (MILLIONS)

TABLE 12 ESTIMATED POPULATIONS OF FARM ANIMALS FOR 2004, BRAZIL (MILLIONS)

TABLE 13 VACCINES BY TARGET SPECIES AND PROVIDERS

TABLE 14 GLOBAL MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, THROUGH 2013 ($ MILLIONS)

TABLE 15 ESTIMATED GLOBAL REVENUES FOR ANIMAL VACCINES BY TYPE, THROUGH 2013 ($ MILLIONS)

TABLE 16 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION, 2007 (%/$ MILLIONS)

TABLE 17 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE, 2007 (%/$ MILLIONS)

TABLE 18 ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES AND PROVIDERS

TABLE 19 ANTI-INFECTIVES BY TARGET SPECIES AND PROVIDERS

TABLE 20 ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES AND PROVIDERS

TABLE 21 METABOLIC DRUGS BY TARGET SPECIES AND PROVIDERS

TABLE 22 PARASITICIDES BY TARGET SPECIES AND PROVIDERS

TABLE 23 OTHER PHARMACEUTICALS BY TARGET SPECIES AND PROVIDERS

TABLE 24 GLOBAL MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE, THROUGH 2013 ($ MILLIONS)

TABLE 25 GLOBAL MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, THROUGH 2013 ($ MILLIONS)

TABLE 26 GLOBAL MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE, THROUGH 2013 ($ MILLIONS)